TongliBio reaches a strategic partnership with Occam Biolabs, Inc.
Time:2020-05-02

5/2/2020. TongliBio reaches a strategic partnership with Occam Biolabs, Inc. in US to co-develop in vitro diagnostic kit for Covid-19 and other zoonoses. Occam Biolabs has developed a proprietary MOES platform technology for molecular diagnostic targeting at varies infectious pathogens and pioneered the technology for tuberculosis molecule diagnosis in human blood.